Cunningham, D., Stenning, S.P., Smyth, E.C., Okines, A.F., Allum, W.H., Rowley, S., et al. (2017) Peri-Operative Chemotherapy with or without Bevacizumab in Operable Oesophagogastric Adenocarcinoma (UK Medical Research Council ST03) Primary Analysis Results of a Multicentre, Open-Label, Randomised Phase 2-3 Trial. The Lancet Oncology, 18, 357-370. - References

Journals by Subject

Publish with us

Follow SCIRP

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Article citationsMore>>

Cunningham, D., Stenning, S.P., Smyth, E.C., Okines, A.F., Allum, W.H., Rowley, S., et al. (2017) Peri-Operative Chemotherapy with or without Bevacizumab in Operable Oesophagogastric Adenocarcinoma (UK Medical Research Council ST03): Primary Analysis Results of a Multicentre, Open-Label, Randomised Phase 2-3 Trial. The Lancet Oncology, 18, 357-370.
https://doi.org/10.1016/S1470-2045(17)30043-8

has been cited by the following article:

TITLE: Current Status and Research Progress of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer

AUTHORS: Junjian Liu, Tian Wei, Zhiping Xiang, Yinlu Ding

KEYWORDS: Locally Advanced Gastric Cancer, Adjuvant Chemotherapy, Neoadjuvant Chemotherapy

JOURNAL NAME: Journal of Biosciences and Medicines, Vol.11 No.3, March 30, 2023

ABSTRACT: Gastric cancer is one of the most common malignant tumours worldwide, with a high degree of malignancy and a poor prognosis. While early gastric cancer can be cured by surgical treatment, locally advanced gastric cancer requires neoadjuvant therapy to shrink the tumour, suppress potential metastases, achieve down-staging, and provide patients with the opportunity for radical surgery to prolong their survival. This article reviews the current status and progress of neoadjuvant chemotherapy for locally advanced gastric cancer.

Open Access

Articles

A Prospective, Open-Label, 12 Week Trial of S-adenosylmethionine in the Symptomatic Treatment of Alzheimer’s Disease

Maja L. Rudolph, Michael Rabinoff, Bruce L. Kagan

Neuroscience and Medicine Vol.2 No.3, September 28, 2011

DOI: 10.4236/nm.2011.23030
Open Access

Articles

Efficacy and Safety of Tinefcon^® Tablets in Subjects with Plaque Psoriasis: An Open Label, Non-Comparative, Multicenter, Phase IV Trial

Somesh Sharma, Kailash Bhatia, Meetesh Agarwal, Sandesh Gupta, Leelavathi Budamakuntla, Sudhakar Grandhi, Vinod Titarmare, Sushil Pande, Ranjan Rawal, Aruna Samarth, Rizwan Haq, Vikrant Saoji, D. V. S. Pratap, L. M. Kansal, D. G. Saple, Shatrughan Sahay, Parag Kalyani, Puneet Goyal, Sharmila Patil, A. J. Kanwar, Bhavesh Swarnakar, Sujay Kulkarni, Abhijeet Morde, Hitesh Khandagale, Yogesh Dound, Nitin Jadhav, Sanjeev Hegde, Murlidhara Padigaru, Ashish C. Suthar

J. of Cosmetics, Dermatological Sciences and Applications Vol.6 No.2, April 25, 2016

DOI: 10.4236/jcdsa.2016.62008
Open Access

Articles

A prospective, open label, 24-week trial of methylcobalamin in the treatment of diabetic polyneuropathy

Jacqueline C. Dominguez, Arlene R. Ng, Ludwig F. Damian

Journal of Diabetes Mellitus Vol.2 No.4, November 27, 2012

DOI: 10.4236/jdm.2012.24064
Open Access

Articles

“Flow” Transcranial Direct Current Stimulation (tDCS) for Depression Treatment in a Primary Healthcare General Practice—An Open-Label Cohort Study Measuring Montgomery-Åsberg Depression Rating Scale (MADRS-S) Outcomes

Chris Griffiths, Harmony Jiang, David Smart, Azhar Zafar

Open Journal of Psychiatry Vol.14 No.4, July 29, 2024

DOI: 10.4236/ojpsych.2024.144024
Open Access

Articles

An open-label trial of divalproex sodium extended release for pediatric bipolar spectrum disorder in children age 6 - 12 years

Janet Wozniak, Paul Hammerness, Robert Doyle, Gagan Joshi, K. Yvonne Woodworth, Joseph Biederman

Open Journal of Psychiatry Vol.2 No.2, April 18, 2012

DOI: 10.4236/ojpsych.2012.22017

Follow SCIRP

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journals by Subject

Publish with us

Article citationsMore>>

Home

About SCIRP

Service

Policies